{"description":"Adverse events were assessed after the insertion procedure, upon notification of a problem by the patient, and when the Provox Vega needed replacement. Normal reasons for replacement (leakage through, size changes) were not considered adverse events.","eventGroups":[{"description":"A group of laryngectomized Provox ActiValve users tested the Provox Vega 22.5 French voice prosthesis for 3 weeks.","id":"EG000","otherNumAffected":0,"otherNumAtRisk":15,"seriousNumAffected":0,"seriousNumAtRisk":15,"title":"Provox Vega 22.5 French"}],"frequencyThreshold":"5","timeFrame":"Adverse Events were recorded from the time the new Vega prosthesis was inserted until the voice prosthesis was replaced"}